![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 46, 44310-44316, November 15, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of
Received for publication, July 25, 2002, and in revised form, September 3, 2002
Recent liver regeneration studies indicate that
maintaining hepatic Forkhead Box M1B (FoxM1B) expression in
12-month-old (old-aged) Transthyretin-FoxM1B transgenic mice increases
hepatocyte proliferation and expression of cell cycle regulatory
genes. Because these transgenic CD-1 mice maintain FoxM1B levels
during the aging process, we conducted the current study to determine
whether adenovirus delivery of the FoxM1B gene (AdFoxM1B) is sufficient
to stimulate liver regeneration in old-aged Balb/c mice. Here we show
that AdFoxM1B infection of old-aged mice caused a significant increase
in FoxM1B expression, hepatocyte DNA replication, and mitosis following partial hepatectomy. This stimulation in hepatocyte S-phase
progression was associated with diminished protein expression and
perinuclear localization of cyclin-dependent kinase (Cdk)
inhibitor p27Kip1 (p27) protein following
partial hepatectomy. In contrast, old-aged mice infected
with control virus displayed high hepatocyte levels of p27 protein,
which had been localized to the nucleus prior to S-phase.
Furthermore, we found that restoring FoxM1B expression did not
influence p27 mRNA levels, and this new finding implicates FoxM1B
in regulation of p27 protein levels. Likewise, AdFoxM1B-infected regenerating livers displayed elevated S-phase levels of Cdk2 kinase
activity compared with old-aged mice infected with control virus.
Furthermore, restoring FoxM1B expression in old-aged mice caused
elevated levels of Cyclin B1, Cyclin B2, Cdc25B, Cdk1, and p55CDC
mRNA as well as stimulating Cdc25B nuclear localization during
liver regeneration, all of which are required for mitosis. These
studies indicated that an acute delivery of the FoxM1B gene in old-aged
mice is sufficient to re-establish proliferation of regenerating
hepatocytes, suggesting that FoxM1B can be used for therapeutic
intervention to alleviate the reduction in cellular proliferation
observed in the elderly.
Liver regeneration induced by two thirds partial hepatectomy
(PHx)1 results in synchronous
induction of hepatocyte proliferation through collaborative stimulation
by growth factors and the interleukin 6 (IL-6) cytokine (1-5). Cell
cycle progression is regulated by cyclin expression and degradation as
well as by cyclin-mediated activation of cyclin-dependent
kinases (Cdks). Formation of the Cyclin E-Cdk2 and Cyclin A-Cdk2
complexes is critical for S-phase entry and progression because they
phosphorylate the retinoblastoma (RB) protein, which releases bound
E2F transcription factor and allows it to stimulate expression
of proliferation-specific target genes (6). Likewise, Cyclin B proteins
associate with Cdk1 (Cdc2) to mediate cell cycle progression from the
G2 phase into mitosis (7). Furthermore, Cdk activity is
stimulated through dephosphorylation by the Cdc25A, Cdc25B, and Cdc25C
phosphatase proteins (8-10) and is negatively regulated by high levels
of Cdk inhibitor p21Cip1, p27Kip1, and
p16INK4A proteins (11). Finally, increased p55CDC protein
levels are required to regulate the ubiquitin-ligase anaphase-promoting
complex (APC)-mediated degradation of the Cyclin B proteins, whose
elimination is required for the completion of mitosis (7).
The Forkhead Box (Fox) transcription factors are an extensive family of
transcription factors, consisting of more than 50 mammalian proteins
(12), which shares homology in the winged helix DNA-binding domain
(13). Its members play important roles in regulating cellular
proliferation, differentiation, and metabolic homeostasis (14-20). In
regenerating liver, increased hepatic expression of FoxM1B levels
occurs at the G1/S transition of the cell cycle (32 h
post-PHx), and its levels remain elevated throughout the period of
proliferation (19, 21). To examine the role of FoxM1B in regulating
cellular proliferation, we developed transgenic (TG) CD-1 mice in which
the Recent studies indicate that diminished expression of FoxM1B and its
cell cycle target genes is associated with reduced proliferation in
regenerating hepatocytes of 12-month-old (old-aged) CD-1 mice (18) and
in proliferating human fibroblasts of the elderly (23). Maintaining
FoxM1B expression in regenerating liver of old-aged TTR-FoxM1B TG mice
is sufficient to increase hepatocyte DNA synthesis and mitosis to
levels found in young (2-month-old) regenerating mouse liver (18).
Furthermore, FoxM1B-mediated stimulation of hepatocyte proliferation
was associated with increased expression of numerous cell cycle
regulatory genes. These include increased expression of S-phase
promoting Cyclin D1 and Cyclin A2 and M-phase promoting Cyclin F,
Cyclin B1, Cyclin B2, Cdc25B, and p55CDC (18). Taken together, these
published studies supported the hypothesis that maintaining FoxM1B
levels will prevent age related decrease in cellular proliferation.
In this study, we showed that regenerating livers of old-aged Balb/c
mice exhibited diminished FoxM1B expression with significant reductions
in hepatocyte proliferation, increased levels of the S-phase inhibitor
p27Kip1 (p27) protein, and reduced expression of the
M-phase promoting CyclinA2, Cyclin B1, Cyclin B2, Cdc25B, Cdk1, and
p55CDC genes. We demonstrated that an adenovirus-mediated increase in
FoxM1B expression (AdFoxM1B) significantly elevated hepatocyte
proliferation in regenerating liver of old-aged Balb/c mice, which was
associated with diminished nuclear expression of the p27 protein and
restoring levels of these M-phase progression genes.
Generation, Purification, and in Vivo Administration of
Recombinant Adenoviruses--
To create the adenovirus expressing
FoxM1B (AdFoxM1B), we subcloned the 2.7-kb
EcoRI-HindIII fragment of the human FoxM1B cDNA into the adenovirus shuttle vector pGEMCMV NEW (a gift from J. R. Nevins, Duke University, Durham, NC). This adenovirus
shuttle vector and the overlapping adenovirus genome were transfected into 293 cells and homologous recombination was used to generate AdFoxM1B as described previously (24). Replication-defective adenovirus, which was deleted in the E1 genes (AdEmpty), was a gift
from P. Raychaudhuri (University of Illinois at Chicago, Chicago, IL).
Recombinant adenoviruses were used to infect QBO-293 cells (Quantum
Biotechnologies, Montreal, Canada), and cell lysates were harvested at
72 h post infection. Adenovirus particles were purified from this
cell lysate by CsCl centrifugation and dialyzed to remove the
CsCl as described previously (25, 26). Two days prior to the PHx
operation, 12-month-old Balb/c mice (purchased from the National
Institutes of Aging, Bethesda, MD) were subjected to tail vein
injection with 200 µl of either phosphate-buffered saline (PBS;
mock-infected) or PBS containing 1 × 1011 purified
adenovirus particles (AdFoxM1B or AdEmpty).
Partial Hepatectomy Surgery, Immunohistochemical Staining, and
Western Blot Analysis--
Two days after infection, all the Balb/c
mice were subjected to PHx to induce liver regeneration as described
previously (18, 19). Three mice at each time point were sacrificed
using CO2 asphyxiation at the following intervals after
PHx: 24, 28, 32, 36, 40, and 44 h. An intraperitoneal injection of
a PBS solution containing 10 mg/ml of 5-bromo-2'-deoxyuridine (BrdUrd,
Sigma; 50 µg/g body weight) was administered 2 h prior to
harvesting the remnant regenerating liver. The regenerating livers were
harvested and divided into three portions: one to isolate total RNA
(19), one to isolate total protein extract (27), and one utilized for
paraffin embedding (28). Determination of the number of hepatocytes
undergoing DNA synthesis was performed by monoclonal antibody detection
of BrdUrd incorporation (Roche) of regenerating liver (5-µm paraffin
sections) using the microwave antigen retrieval method described
previously (19). Using three regenerating livers per time point, we
counted the number of BrdUrd-positive nuclei per 1000 hepatocytes to
calculate the mean number of BrdUrd-positive cells (± S.D.) as
described previously (19). Three regenerating liver sections at 36, 40, and 44 h post-PHx were stained with Hematoxylin and Eosin and
examined for mitotic figures (mitosis). Hepatocyte mitosis is expressed
as the mean of the number of mitotic figures found per 1000 hepatocytes ± S.D. as described previously (19).
Adenovirus-infected and mock-infected mice undergoing liver
regeneration were given free access to food and water.
The FoxM1B (HFH-11B) antibody specific to the amino terminus (19, 21),
p27 antibody (Cell Signaling, Berkeley, CA), or Cdc25B antibody
(Santa Cruz Biotechnology, Santa Cruz, CA) was used
for immunohistochemical detection of paraffin-embedded 5 µM sections of regenerating liver using methods described
previously (19, 21). Prior to FoxM1B immunohistochemical staining,
regenerating liver sections were subjected to a 15-min proteinase K
antigen retrieval step (20 µg/ml Proteinase K, Invitrogen) in PBS at
room temperature and then rinsed in PBS.
For Western blot analysis, 50 µg of total liver protein (27) was
separated on SDS-PAGE and transferred to a Protran membrane (Schleicher
& Schuell, Keene, NH). The signal from the primary p27Kip1
antibody (Cell Signaling) was amplified by biotin-conjugated anti-rabbit IgG (Bio-Rad, Hercules, CA), and signals were detected with Enhanced Chemiluminescence Plus (ECL-plus, Amersham
Biosciences). Cdk2 kinase assays were performed by
immunoprecipitation of active Cdk2 enzyme from 200 µg of total liver
protein with Cdk2 antibody (Santa Cruz Biotechnology.) and Protein
A-Sepharose beads (Amersham Biosciences), and nonspecific proteins were
removed by repetitive washes as described in Kiyokawa et al.
(29). The Cdk2 kinase reaction involved addition of the Rb protein
(Santa Cruz Biotechnology) with [ Isolation of Total Liver RNA and RNase Protection
Assay--
Total RNA was prepared from mouse liver at indicated hours
post-PHx using RNA-STAT-60 (Tel-Test "B" Inc., Friendswood, TX) and
used for RNase protection assays with antisense
[ Adenovirus-mediated Increase in FoxM1B Levels Restores Regenerating
Hepatocyte Proliferation in Old-aged Mice--
Maintaining hepatocyte
FoxM1B levels in 12-month-old (old-aged) TTR-FoxM1B TG CD-1 mice
stimulated both proliferation of regenerating hepatocytes and
expression of cell cycle regulatory genes (18). Because these TG CD-1
mice sustained FoxM1B expression throughout the aging process, we
sought to determine whether an acute adenovirus-mediated delivery of
hepatic FoxM1B protein (AdFoxM1B) to old-aged Balb/c mice would
stimulate proliferation of regenerating hepatocytes. To avoid the
initial acute phase response to viral infection, which subsides within
36 h following adenovirus infection (30), we chose to perform the
PHx two days after adenovirus infection. 12-month-old (old-aged) Balb/c
mice were infected with either replication-defective control adenovirus
(AdEmpty) or AdFoxM1B by tail vein injection and then subjected to PHx
operations two days later. The remnant regenerating livers were
harvested at different intervals between 24 and 44 h following
surgery for analysis of hepatocyte proliferation and expression of cell
cycle genes. Hepatocyte DNA synthesis was monitored by
immunohistochemical staining of BrdUrd incorporation into DNA as
described previously (18).
RNase protection assays with regenerating liver RNA demonstrated that
only AdFoxM1B-infected old-aged mice exhibited increased hepatic FoxM1B
mRNA that resembled levels observed with young (2-month-old) mouse
liver at 40 h after PHx (Fig.
1A). AdFoxM1B infection of
old-aged mice increased the peak of regenerating hepatocyte DNA
replication and mitosis (Fig. 1, B and C)
compared with mock-infected (MI) or AdEmpty-infected adenovirus
controls (Fig. 1, B and C). Furthermore,
AdFoxM1B-infected old-aged mice displayed an 8-h acceleration in the
peak of hepatocyte DNA replication occurring at 32 h post-PHx
(Fig. 1B, red line) compared with a DNA
replication peak at 40 h after PHx found with young regenerating liver (Fig. 1B, black line). This accelerated DNA
replication peak was associated with earlier hepatocyte FoxM1B nuclear
staining at 24 h post-PHx (Fig.
2A) compared with 36-40 h
post-PHx for young regenerating mouse liver (Fig. 2B). In
contrast, no FoxM1B nuclear staining was found in either MI- or
AdEmpty-infected old-aged mouse controls (Fig. 2, C and
D). These results suggest that earlier FoxM1B nuclear
staining is associated with accelerated hepatocyte DNA replication in
regenerating liver of AdFoxM1B-infected old-aged mice.
AdFoxM1B Infection of Old-aged Mice Causes Diminished
p27Kip1 Protein Levels and Increased Cdk2 Kinase
Activity--
The p27Kip1 (p27) protein associates with
Cdk2 and inhibits kinase activity of the Cyclin E-Cdk2 and Cyclin
A2-Cdk2 complexes (11). S-phase progression requires Cyclin-Cdk2
protein phosphorylation of the RB protein, which causes dissociation of
RB and activates the E2F transcription factor (6). Because the related
FoxO1 and FoxO3 (previously called FKHR) transcription factors are
known to stimulate expression of p27 (31), we next examined whether AdFoxM1B infection could influence expression of the p27 protein. We
subjected regenerating liver protein extracts to Western blot analysis
using a commercially available p27 antibody (Fig.
3). These data demonstrated that either
MI- or AdEmpty-infected old-aged mice displayed an elevated expression
of p27 protein (Fig. 3, B and D), whereas reduced
hepatic p27 levels were found in both young mice and AdFoxM1B-infected
old-aged mice following PHx (Fig. 3, A and C).
Interestingly, we found that AdFoxM1B infection did not alter p27
mRNA levels (Fig. 3, E and F), suggesting
that FoxM1B is regulating p27 protein levels rather than controlling
its promoter activity. Furthermore, immunohistochemical staining of
regenerating liver sections demonstrated that MI- and AdEmpty-infected
old-aged mice displayed abundant p27 nuclear staining prior to S-phase (Fig. 4, A, B,
D, and E). In contrast, AdFoxM1B-infected
old-aged mice displayed only perinuclear hepatocyte staining of p27
protein following PHx (Fig. 4, G-I), a finding consistent
with stimulating S-phase progression (11). Furthermore, although MI-
and AdEmpty-infected old-aged mice displayed perinuclear staining of
p27 protein at 40 h post-PHx (Fig. 4, C and
F), this delayed change in p27 cellular localization was
unable to facilitate S-phase progression. Collectively, these
liver regeneration studies suggest that FoxM1B mediates S-phase
progression in old-aged mice by diminishing nuclear expression of the
p27 protein.
To examine whether diminished p27 protein levels were associated with
increased Cdk2 kinase activity, regenerating liver protein extracts
prepared from either AdEmpty- or AdFoxM1B-infected old-aged mice were
immunoprecipitated with Cdk2 antibody and then used to phosphorylate
recombinant RB protein. These experiments demonstrated that diminished
S-phase levels of p27 protein were associated with elevated Cdk2 kinase
activity in AdFoxM1B-infected regenerating liver (Fig.
5B) compared with
AdEmpty-infected controls (Fig. 5A). These results suggest
that AdFoxM1B infection of old-aged mice diminished nuclear expression
of p27 protein in regenerating hepatocytes, which allowed complex
formation of the active Cyclin E-Cdk2 and Cyclin A-Cdk2 complexes
required for S-phase progression.
AdFoxM1B Infection of Old-aged Mice Increases Regenerating Liver
Expression of Cell Cycle Regulatory Genes and Nuclear Staining of
Cdc25B Phosphatase--
RNase protection assays were performed in
triplicate with cell cycle regulatory gene probes, and regenerating
liver RNA was isolated between 24 and 44 h following PHx (Fig.
6, A-D). In
2-month-old (young) regenerating mouse liver, increased S-phase levels
of Cyclin A2, Cyclin B1, and Cyclin B2 mRNA occurred at 40 h
post-PHx (Fig. 6, E-G). We found that
regenerating liver of AdFoxM1B-infected old-aged mice displayed
increased S-phase levels of Cyclin A2, Cyclin B1, and Cyclin B2
mRNA at 32 h post-PHx (Fig. 6, E-G)
compared with either MI- or AdEmpty-infected old-aged mouse controls
(Fig. 6, E-G). Furthermore, expression levels of
these genes diminished during mitosis, which occurred at 36 h
following PHx (Fig. 6, E-G). In addition,
expression of mitosis promoting Cdc25B phosphatase, Cdk1, and p55CDC
mRNA initiated prior to S-phase between 32 and 36 h following
PHx in young regenerating liver (Fig.
7B, arrow). Likewise, AdFoxM1B-infected regenerating liver initiated expression of
Cdc25B, p55CDC, and Cdk1 mRNA prior to S-phase at 24 h after PHx (Fig. 7D, arrow), whereas these mRNA
levels were diminished in regenerating liver of either MI- or
AdEmpty-infected old-aged mouse controls (Fig. 7, A and
C). Immunohistochemical staining of regenerating liver
sections revealed a biphasic nuclear staining of Cdc25B phosphatase
protein prior to and following S-phase (Fig. 8, D-F), a finding
consistent with the ability of Cdc25B to activate Cdk1 as required for
M-phase progression (8-10). In contrast, low levels of either nuclear
or perinuclear hepatocyte staining of Cdc25B protein were found at
28 h post-PHx in AdEmpty-infected old-aged liver (Fig.
8A). Furthermore, only perinuclear hepatocyte staining of
the Cdc25B protein was found at later time points following PHx (Fig.
8, A-C, and data not shown). These results suggest that FoxM1B-stimulated proliferation of regenerating
hepatocytes is associated with increased expression of S-phase
promoting Cyclin A genes and M-phase promoting Cyclin B1, Cyclin B2,
Cdc25B, and p55CDC genes.
Previous liver regeneration studies demonstrated that maintaining
hepatic expression of FoxM1B in 12-month-old (old-aged) TTR-FoxM1B TG
mice is sufficient to increase regenerating hepatocyte proliferation
and expression of numerous cell cycle regulatory genes (18). In this
study we demonstrate that AdFoxM1B infection of old-aged mice prior to
PHx elevated FoxM1B expression levels and increased hepatocyte DNA
replication and mitosis compared with either MI- or AdEmpty-infected
controls. This stimulation in hepatocyte S-phase progression was
associated with diminished expression of the Cdk inhibitor
p27Kip1 (p27) protein and sustained perinuclear staining of
the p27 protein. In contrast, old-aged mice infected with control virus
displayed high hepatocyte levels of p27 protein, which had been
localized to the nucleus prior to S-phase. Interestingly, we found that AdFoxM1B infection did not alter p27 mRNA levels, a new result demonstrating that FoxM1B participates in regulating nuclear expression of the p27 protein rather than controlling its promoter expression. Furthermore, we found increased S-phase levels of Cyclin A2 mRNA and Cdk2 kinase activity, both of which are consistent with
enhanced hepatocyte DNA replication (7, 11). Moreover, AdFoxM1B
infection of old-aged mice caused elevated expression of Cyclin B1,
Cyclin B2, Cdc25B, Cdk1, and p55CDC mRNA in regenerating livers,
all of which are required for mitosis (7). Finally, we showed that increased FoxM1B levels in regenerating old-aged hepatocytes enhanced nuclear staining of Cdc25B protein, a phosphatase, which stimulated Cdk1 activity required for entry into mitosis (8-10). These
studies indicated that an acute delivery of FoxM1B gene in old-aged
mice was sufficient to re-establish regenerating hepatocyte
proliferation, suggesting that FoxM1B is a candidate for therapeutic
intervention to ameliorate diminished proliferation observed in the elderly.
Activation of Cdk activity through the formation of CyclinD1-Cdk 4/6
and Cyclin E-Cdk2 complexes is required to phosphorylate the RB protein
and mediate release of the E2F transcription factor to activate
expression of its proliferation-specific target genes (6). Unlike liver
regeneration studies with old-aged wild type and TG CD-1 mice
(18), we did not find significant differences in Cyclin D1 and Cyclin E
expression between old-aged and young Balb/c mice. However, AdFoxM1B
infection was able to stimulate S-phase levels of Cyclin A2 mRNA
and diminish nuclear expression of the p27 protein, which was elevated
in old-aged mouse liver (Figs. 3 and 4). A transient reduction in p27
protein levels is required for activation of Cyclin E-Cdk2 and Cyclin
A2-Cdk2 kinase complex, which is essential to mediate progression into
S-phase through maintenance of RB phosphorylation and E2F
transcriptional activity (6). Consistent with this finding,
AdFoxM1B-infected regenerating liver displayed increased S-phase Cdk2
activity using the RB protein substrate compared with AdEmpty-infected
old-aged mouse controls. Moreover, the active Cyclin A2-Cdk2 kinase
complex is required to phosphorylate the cdh1 subunit of the
ubiquitin-ligase APC, which prevents APC-mediated degradation of Cyclin
B at the end of S-phase and thus allows Cyclin B accumulation to
promote entry into mitosis (6).
More recent studies demonstrate that in proliferating mammalian cells
the phosphatidylinositol 3'-kinase (PI3K)/Akt signal transduction
pathway is essential for G1 to S-phase progression because
it prevents transcriptional activity of the FoxO1 and FoxO3 (previously
called FKHR) proteins, which stimulate transcription of the Cdk
inhibitor p27Kip1 gene (31). Activation of the PI3K
signaling pathway stimulates the Akt kinase, which phosphorylates the
C-terminus of the FoxO1 (Fkhr; Daf-16) protein and mediates its nuclear
export into the cytoplasm, thus preventing FoxO1 transcriptional
activation of target genes (32-34). Unlike the FoxO protein, whose
transcriptional inhibition is required for cell cycle progression,
elevated FoxM1B expression mediates S-phase progression by
diminishing nuclear expression of the p27 protein. Interestingly,
increased FoxM1B expression did not alter p27 mRNA levels,
indicating that FoxM1B regulates p27 protein levels rather than
influencing its promoter activity. During G1 phase of the
cell cycle, the p27 protein is negatively regulated by phosphorylation,
which mediates association with the Jab1 protein, which mediates p27
nuclear export using a CRM1-dependent mechanism and its
subsequent proteosome-mediated degradation (35-38). Interestingly, we
find that restoring FoxM1B expression causes perinuclear hepatocyte
staining of the p27 protein in old-aged regenerating liver. It is
therefore tempting to speculate that FoxM1B causes diminished p27
protein levels through CRM-1-mediated p27 nuclear export and
degradation. Previous co-transfection studies in tissue culture cells
demonstrated that FoxM1B over-expression could activate transcription
of the Cyclin D1 and Cyclin B1 promoters (18). Our present study shows,
for the first time, that FoxM1B is capable of directly or indirectly
regulating nuclear expression of the p27 protein, which potentiates
formation of the Cyclin-Cdk2 complexes required to stimulate hepatocyte
S-phase progression.
Consistent with our previous liver regeneration studies in old-aged TG
mice, increased FoxM1B levels stimulated expression of M-phase
promoting Cyclin B1, Cyclin B2, and Cdk1 genes. Cyclin B proteins
associate with Cdk1 to mediate cell cycle progression from the
G2 phase into mitosis (7). Furthermore, AdFoxM1B infection of regenerating old-aged liver increased expression of Cdc25B and
p55CDC genes, which was undetectable in either MI- or AdEmpty-infected controls. Elevated FoxM1B levels were associated with increased Cdc25B
nuclear staining of regenerating hepatocytes, a new finding consistent
with stimulating M-phase progression. The Cdc25B phosphatase promotes
M-phase progression by dephosphorylation of the Cdk1 Tyr-15 and Thr-14
residues, thereby activating the mitotic Cdk1/Cyclin B kinase
(8-10). Microinjection of the Cdc25B protein, but not the Cdc25C
protein, can drive replicating cells into mitosis, suggesting that
Cdc25B regulates entry into mitosis (39). The fact that increased
FoxM1B levels re-established appropriate increased expression of Cdc25B
is consistent with the ability of FoxM1B to restore mitosis in
regenerating liver of old-aged mice. Finally, FoxM1B-mediated increase
in p55CDC levels is required to exit mitosis through its regulation of
the ubiquitin-ligase APC degradation of the Cyclin proteins (7).
In summary, reduced expression of the FoxM1B transcription factor
contributes to the decline in regenerating hepatocyte proliferation observed in old-aged mice. We show that adenovirus delivery of the
FoxM1B gene was sufficient to restore FoxM1B expression and stimulated
hepatocyte proliferation in regenerating liver of old-aged mice.
Increased FoxM1B levels diminished nuclear p27 levels and stimulated
expression of the necessary cell cycle regulatory genes.
We thank H. Kiyokawa for assistance with the
Cdk2 kinase assays and Nai-Jung Hung for technical assistance. We also
thank P. Raychaudhuri, V. Kalinichenko, Y. Zhou, M. Major, and F. Rausa for critically reviewing the manuscript.
*
This work was supported by National Institutes of Health
Grant R01 DK 54687-04 (to R. H. C.) from the National Institute of Diabetes and Digestive and Kidney Diseases.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Molecular
Genetics (M/C 669), University of Illinois at Chicago, College of
Medicine, 900 S. Ashland Ave., Rm. 2220 MBRB, Chicago, IL
60607-7170. Tel.: 312-996-0474; Fax: 312-355-4010; E-mail:
Robcosta@uic.edu.
Published, JBC Papers in Press, September 6, 2002, DOI 10.1074/jbc.M207510200
The abbreviations used are:
PHx, partial
hepatectomy;
Fox, Forkhead Box;
FoxM1B, Forkhead Box M1B;
AdFoxM1B, adenovirus-expressing FoxM1B;
AdEmpty, replication-defective adenovirus
control lacking the E1 region;
MI, mock-infected;
TG, transgenic;
APC, anaphase-promoting complex;
Cdk, cyclin-dependent kinase;
TTR, Transthyretin;
p27Kip1, Cdk inhibitor;
RB, retinoblastoma;
PBS, phosphate-buffered saline;
BrdUrd, 5-bromo-2'-deoxyuridine.
Increased Hepatic Forkhead Box M1B (FoxM1B) Levels in Old-aged
Mice Stimulated Liver Regeneration through Diminished
p27Kip1 Protein Levels and Increased Cdc25B Expression*
,
,
,
,
¶
Molecular Genetics and
§ Oral Medicine and Diagnostic Sciences, University of
Illinois at Chicago, College of Medicine and Dentistry,
Chicago, Illinois 60607
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
3-kb Transthyretin (TTR) promoter was used to drive
hepatocyte expression of the human FoxM1B (HFH-11B) cDNA (19).
Using these TG mice for liver regeneration studies, we found that
premature FoxM1B expression caused an 8-h acceleration of hepatocyte
entry into S-phase and mitosis and earlier expression of genes involved
in regulating cell cycle progression (19, 22).
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-32P]ATP to
immunoprecipitated Cdk2 protein bound to the Protein A-Sepharose beads.
The kinase reaction was incubated for 30 min at 37 °C, and one-half
of the Cdk2 kinase reaction was separated by SDS/PAGE and exposed to a
phosphorimaging screen. Quantitation of Cdk2-mediated Rb
phosphorylation was performed with the Storm 860 PhosphorImager and the ImageQuant program (Amersham Biosciences).
-32P]UTP-labeled probes specific to cell cycle
regulatory genes as described previously (18, 22). The 600-nucleotide
mouse p27 cDNA (a gift from H. Kiyokawa) was digested with
AvaII, and a 200-nucleotide antisense RNA probe was
synthesized from this template. RNase protection assay gels were also
exposed to phosphorimaging screens for 1 or 2 days and scanned with a
Storm 860 PhosphorImager and quantitated with the ImageQuant program.
Expression levels were normalized to either cyclophilin or
glyceraldehyde-3-phosphate dehydrogenase mRNA levels. Mean mRNA
levels ± S.D. were determined from three distinct regenerating livers.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES

View larger version (52K):
[in a new window]
Fig. 1.
Adenovirus-mediated increase in hepatic
FoxM1B expression elevated the peak of regenerating hepatocyte DNA
replication and mitosis in old-aged mice. 12-month-old mice were
subjected to tail vein injections with either adenovirus-empty
(Ad-empty) or adenovirus FoxM1B (AdFoxM1B) or
mock-infected (MI) controls, which included tail vein
injection with PBS. Two days after injection, mice were subjected to a
PHx operation, and remnant regenerating liver was harvested at
designated time points following PHx. At least three regenerating mouse
livers were used for each time point. A, AdFoxM1B-infected
regenerating liver displayed increased FoxM1B levels in old-aged
mice. RNase protection assay was performed to detect the
expression of the endogenous mouse Foxm1b gene in MI- and
AdEmpty-infected livers and FoxM1B levels in AdFoxM1B-infected livers.
Cyclophilin levels were used to normalize FoxM1B expression levels.
Shown below the panels is the fold increase in
Foxm1b expression levels in comparison with 2-month-old regenerating
liver at the 24-h time point. B, the peak of regenerating
hepatocyte DNA replication was increased in AdFoxM1B-infected old-aged
mice. DNA replication in regenerating liver sections was detected by
immunohistochemical staining of BrdUrd incorporation. The mean number
of the BrdUrd-positive hepatocytes per 1000 cells (± S.D.) from three
regenerating mouse livers per time point was plotted against the hours
following PHx. C, the peak of regenerating hepatocyte
mitosis was increased in AdFoxM1B-infected old-aged mice. Regenerating
liver sections were stained with hematoxylin and eosin and used
to detect mitotic figures (mitosis) between 36 and 44 h following
PHx from three regenerating mouse livers per time point. Graphic
representation of the mean number of mitotic figures per 1000 hepatocytes (± S.D.) from three regenerating mouse livers per time
point was plotted against the hours following PHx.

View larger version (149K):
[in a new window]
Fig. 2.
Regenerating liver of AdFoxM1B-infected
old-aged mice displayed earlier nuclear FoxM1B staining.
Regenerating liver sections were subjected to immunohistochemical
staining with an amino-terminal FoxM1B antibody. This includes
regenerating liver from either AdFoxM1B-infected 12-month-old (12 M) (A), mock-infected (MI) 2-month-old
(B), MI 12-month-old (C), or AdEmpty-infected
12-month-old (D) Balb/c mice. Shown are regenerating liver
sections isolated at 24, 32, or 40 h following PHx.
Arrows indicate representative FoxM1B nuclear staining.
Magnification for panels A, C, and D
are 400× and panel B is 630×.

View larger version (69K):
[in a new window]
Fig. 3.
AdFoxM1B infection of old-aged mice causes
diminished p27kip1 protein levels regenerating liver.
Total protein extracts were isolated from regenerating liver and
analyzed for p27kip1 protein (p27) expression by Western
blot analysis. This included regenerating liver from MI 2-month-old
(2 M) (A), MI 12-month-old (12 M)
(B), AdFoxM1B-infected 12-month old (C), or
AdEmpty-infected 12-month-old (D) Balb/c mice. Mean
p27 protein levels were normalized to
-actin protein levels, and the
p27 protein levels of 2-month-old regenerating mouse liver at 24 h
post-PHx were set at 1.0. Note that in FoxM1B-infected old-aged mice,
the DNA replication peak occurs at 32 h post-PHx, whereas in young
mice it occurs at 40 h post-PHx. E and F,
AdFoxM1B infection does not alter p27 mRNA levels. RNase protection
assay was performed to detect p27 mRNA in either AdEmpty-infected
or AdFoxM1B-infected livers of 12-month-old mice. Cyclophilin levels
were used as internal control.

View larger version (183K):
[in a new window]
Fig. 4.
AdFoxM1B-infected old-aged mice display
perinuclear p27 staining in regenerating hepatocytes. Regenerating
liver sections were subjected to immunohistochemical staining with a
p27 antibody. This includes regenerating liver from either MI
12-month-old (A-C), AdEmpty-infected
12-month-old (D-F), or AdFoxM1B-infected
12-month-old (G-I) Balb/c mice. Shown are
regenerating liver sections isolated at 24 or 28, 36, and 40 h
following PHx. Note that the DNA replication peak occurs at 32 h
post-PHx in AdFoxM1B-infected old-aged mice, whereas it occurs at
40 h post-PHx in either MI- or AdEmpty-infected old-aged mice.
Arrows indicate representative p27 staining, which is either
nuclear in MI- and AdEmpty-infected old-aged mice or perinuclear in
AdFoxM1B-infected mice.
![]()
View larger version (14K):
[in a new window]
Fig. 5.
AdFoxM1B infection of old-aged mice causes
increased Cdk2 activity in regenerating liver. A and
B, increased Cdk2 activity in AdFoxM1B-infected 12-month-old
Balb/c mice compared with AdEmpty-infected controls. Total protein
extracts were isolated from regenerating liver, immunoprecipitated with
Cdk2 antibody, and used for Cdk2 kinase assays with RB protein
substrate. Position of the phosphorylated RB protein is indicated on
the panels.

View larger version (48K):
[in a new window]
Fig. 6.
Increased Cyclin A2, Cyclin B1, and Cyclin B2
mRNA levels during liver regeneration of AdFoxM1B-infected old-aged
mice. Total RNA was isolated from regenerating liver and analyzed
for cyclin expression by RNase protection assays (in triplicate) with
cyclin templates (BD Biosciences). This included regenerating liver
from mock-infected 12-month-old (A), mock-infected
2-month-old (B), AdEmpty-infected 12-month-old
(C), or AdFoxM1B-infected 12-month-old (D) Balb/c
mice. Note that representative duplicate samples are shown and that
ribosomal protein L32-3A and glyceraldehyde-3-phosphate dehydrogenase
were used to normalize expression levels. E-G,
graphic representation of S-phase increase in Cyclin A2, Cyclin B1, and
Cyclin B2 mRNA levels during liver regeneration of
AdFoxM1B-infected old-aged mice. Graphic presentation of normalized
mean mRNA levels of Cyclin A2 (E), Cyclin B1
(F), and Cyclin B2 (G) at various intervals in
regenerating liver (in triplicate). Mean mRNA expression levels (± S.D.) of cycle regulatory genes were normalized to the
glyceraldehyde-3-phosphate dehydrogenase and Lys-32 mRNA levels.
Mean mRNA expression levels of MI 2-month-old regenerating mouse
liver at 24 h post-PHx were set at 1.0.

View larger version (76K):
[in a new window]
Fig. 7.
Increased Cdc25B, p55CDC, and Cdk1 mRNA
levels during liver regeneration of AdFoxM1B-infected old-aged
mice. Total RNA was isolated from regenerating liver and analyzed
for RNA expression by RNase protection assays (in triplicate) with
Cdc25B, p55CDC, and Cdk1 probes. This includes regenerating liver from
MI 12-month-old (A), MI 2-month-old (B),
AdEmpty-infected 12-month-old (C), or AdFoxM1B-infected
12-month old (D) Balb/c mice. Note that representative
duplicate samples are shown. Expression levels were normalized to
cyclophilin internal control. The relative fold induction of expression
is indicated below the panels for Cdk1.
Expression levels of the MI 2-month-old regenerating mouse liver at
24 h post-PHx were set at 1.0. Note that Cdc25B and p55CDC levels
were undetectable in regenerating livers from either MI- or
AdEmpty-infected 12-month-old mice. Arrows indicate the
onset of expression of p55CDC, Cdc25B, and Cdk-1 during liver
regeneration.

View larger version (187K):
[in a new window]
Fig. 8.
Increased hepatocyte nuclear staining of
Cdc25B protein prior to S-phase in liver regeneration of
AdFoxM1B-infected old-aged mice. Regenerating liver sections were
subjected to immunohistochemical staining with a Cdc25B antibody. This
includes regenerating liver from either AdEmpty-infected 12-month-old
(A-C) or AdFoxM1B-infected 12-month-old
(D-F) Balb/c mice. Shown are regenerating liver
sections isolated at 28, 32, or 40 h following PHx.
Arrows indicate representative Cdc25B nuclear
staining.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Cressman, D. E.,
Greenbaum, L. E.,
DeAngelis, R. A.,
Ciliberto, G.,
Furth, E. E.,
Poli, V.,
and Taub, R.
(1996)
Science
274,
1379-1383 2.
Diehl, A. M.
(2000)
Immunol. Rev.
174,
160-171[CrossRef][Medline]
[Order article via Infotrieve]
3.
Michalopoulos, G. K.,
and DeFrances, M. C.
(1997)
Science
276,
60-66 4.
Taub, R.,
Greenbaum, L. E.,
and Peng, Y.
(1999)
Semin. Liver Dis.
19,
117-127[Medline]
[Order article via Infotrieve]
5.
Yamada, Y.,
Kirillova, I.,
Peschon, J. J.,
and Fausto, N.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1441-1446 6.
Harbour, J. W.,
and Dean, D. C.
(2000)
Genes Dev.
14,
2393-2409 7.
Zachariae, W.,
and Nasmyth, K.
(1999)
Genes Dev.
13,
2039-2058 8.
Nilsson, I.,
and Hoffmann, I.
(2000)
Prog. Cell Cycle Res.
4,
107-114[Medline]
[Order article via Infotrieve]
9.
Sebastian, B.,
Kakizuka, A.,
and Hunter, T.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
3521-3524 10.
Trembley, J. H.,
Ebbert, J. O.,
Kren, B. T.,
and Steer, C. J.
(1996)
Cell Growth & Differ.
7,
903-916[Abstract]
11.
Sherr, C. J.,
and Roberts, J. M.
(1999)
Genes Dev.
13,
1501-1512 12.
Kaestner, K. H.,
Knochel, W.,
and Martinez, D. E.
(2000)
Genes Dev.
14,
142-146 13.
Clark, K. L.,
Halay, E. D.,
Lai, E.,
and Burley, S. K.
(1993)
Nature
364,
412-420[CrossRef][Medline]
[Order article via Infotrieve]
14.
Costa, R. H.,
Kalinichenko, V. V.,
and Lim, L.
(2001)
Am. J. Physiol. Lung Cell Mol. Physiol.
280,
L823-L838 15.
Duncan, S. A.
(2000)
Dev. Dyn.
219,
131-142[CrossRef][Medline]
[Order article via Infotrieve]
16.
Kaestner, K. H.
(2000)
Trends Endocrinol. Metab.
11,
281-285[CrossRef][Medline]
[Order article via Infotrieve]
17.
Kaufmann, E.,
and Knochel, W.
(1996)
Mech. Dev.
57,
3-20[CrossRef][Medline]
[Order article via Infotrieve]
18.
Wang, X.,
Quail, E.,
Hung, N.-J.,
Tan, Y., Ye, H.,
and Costa, R. H.
(2001)
Proc. Natl. Acad. Sci. U. S. A.
98,
11468-11473 19.
Ye, H.,
Holterman, A.,
Yoo, K. W.,
Franks, R. R.,
and Costa, R. H.
(1999)
Mol. Cell. Biol.
19,
8570-8580 20.
Zaret, K.
(1999)
Dev. Biol.
209,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
21.
Ye, H.,
Kelly, T. F.,
Samadani, U.,
Lim, L.,
Rubio, S.,
Overdier, D. G.,
Roebuck, K. A.,
and Costa, R. H.
(1997)
Mol. Cell. Biol.
17,
1626-1641[Abstract]
22.
Wang, X.,
Hung, N.-J.,
and Costa, R. H.
(2001)
Hepatology
33,
1404-1414[CrossRef][Medline]
[Order article via Infotrieve]
23.
Ly, D. H.,
Lockhart, D. J.,
Lerner, R. A.,
and Schultz, P. G.
(2000)
Science
287,
2486-2492 24.
Schwarz, J. K.,
Bassing, C. H.,
Kovesdi, I.,
Datto, M. B.,
Blazing, M.,
George, S.,
Wang, X. F.,
and Nevins, J. R.
(1995)
Proc. Natl. Acad. Sci. U. S. A.
92,
483-487 25.
Tan, Y.,
Costa, R. H.,
Kovesdi, I.,
and Reichel, R. R.
(2001)
Gene Expr.
9,
237-248[Medline]
[Order article via Infotrieve]
26.
Tan, Y.,
Hughes, D. E.,
Wang, X.,
and Costa, R. H.
(2002)
Hepatology
35,
30-39[CrossRef][Medline]
[Order article via Infotrieve]
27.
Rausa, F. M.,
Tan, Y.,
Zhou, H.,
Yoo, K.,
Stolz, D. B.,
Watkins, S.,
Franks, R. R.,
Unterman, T. G.,
and Costa, R. H.
(2000)
Mol. Cell. Biol.
20,
8264-8282 28.
Rausa, F. M., Ye, H.,
Lim, L.,
Duncan, S. A.,
and Costa, R. H.
(1998)
Methods.
16,
29-41[CrossRef][Medline]
[Order article via Infotrieve]
29.
Kiyokawa, H.,
Kineman, R. D.,
Manova-Todorova, K. O.,
Soares, V. C.,
Hoffman, E. S.,
Ono, M.,
Khanam, D.,
Hayday, A. C.,
Frohman, L. A.,
and Koff, A.
(1996)
Cell
85,
721-732[CrossRef][Medline]
[Order article via Infotrieve]
30.
Benihoud, K.,
Salone, B.,
Esselin, S.,
Opolon, P.,
Poli, V., Di,
Giovine, M.,
Perricaudet, M.,
and Saggio, I.
(2000)
J. Gene Med.
2,
194-203[CrossRef][Medline]
[Order article via Infotrieve]
31.
Medema, R. H.,
Kops, G. J.,
Bos, J. L.,
and Burgering, B. M.
(2000)
Nature
404,
782-787[CrossRef][Medline]
[Order article via Infotrieve]
32.
Biggs, W. H., III,
Meisenhelder, J.,
Hunter, T.,
Cavenee, W. K.,
and Arden, K. C.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
7421-7426 33.
Brunet, A.,
Bonni, A.,
Zigmond, M. J.,
Lin, M. Z.,
Juo, P., Hu, L. S.,
Anderson, M. J.,
Arden, K. C.,
Blenis, J.,
and Greenberg, M. E.
(1999)
Cell
96,
857-868[CrossRef][Medline]
[Order article via Infotrieve]
34.
Guo, S.,
Rena, G.,
Cichy, S., He, X.,
Cohen, P.,
and Unterman, T.
(1999)
J. Biol. Chem.
274,
17184-17192 35.
Hara, T.,
Kamura, T.,
Nakayama, K.,
Oshikawa, K.,
and Hatakeyama, S.
(2001)
J. Biol. Chem.
276,
48937-48943 36.
Rodier, G.,
Montagnoli, A., Di,
Marcotullio, L.,
Coulombe, P.,
Draetta, G. F.,
Pagano, M.,
and Meloche, S.
(2001)
EMBO J.
20,
6672-6682[CrossRef][Medline]
[Order article via Infotrieve]
37.
Tomoda, K.,
Kubota, Y.,
Arata, Y.,
Mori, S.,
Maeda, M.,
Tanaka, T.,
Yoshida, M.,
Yoneda-Kato, N.,
and Kato, J. Y.
(2002)
J. Biol. Chem.
277,
2302-2310 38.
Tomoda, K.,
Kubota, Y.,
and Kato, J.
(1999)
Nature
398,
160-165[CrossRef][Medline]
[Order article via Infotrieve]
39.
Karlsson, C.,
Katich, S.,
Hagting, A.,
Hoffmann, I.,
and Pines, J.
(1999)
J. Cell Biol.
146,
573-584
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
A. Kamat, P. M. Ghosh, R. L. Glover, B. Zhu, C.-K. Yeh, G. G. Choudhury, and M. S. Katz Reduced Expression of Epidermal Growth Factor Receptors in Rat Liver During Aging J. Gerontol. A Biol. Sci. Med. Sci., July 1, 2008; 63(7): 683 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. K. M. Li, D. K. Smith, W. Y. Leung, A. M. S. Cheung, E. W. F. Lam, G. P. Dimri, and K.-M. Yao FoxM1c Counteracts Oxidative Stress-induced Senescence and Stimulates Bmi-1 Expression J. Biol. Chem., June 13, 2008; 283(24): 16545 - 16553. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Petrovic, R. H. Costa, L. F. Lau, P. Raychaudhuri, and A. L. Tyner FoxM1 Regulates Growth Factor-induced Expression of Kinase-interacting Stathmin (KIS) to Promote Cell Cycle Progression J. Biol. Chem., January 4, 2008; 283(1): 453 - 460. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Masumoto, C. Tateno, A. Tachibana, R. Utoh, Y. Morikawa, T. Shimada, H. Momisako, T. Itamoto, T. Asahara, and K. Yoshizato GH enhances proliferation of human hepatocytes grafted into immunodeficient mice with damaged liver J. Endocrinol., September 1, 2007; 194(3): 529 - 537. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, S. Banerjee, D. Kong, Y. Li, and F. H. Sarkar Down-regulation of Forkhead Box M1 Transcription Factor Leads to the Inhibition of Invasion and Angiogenesis of Pancreatic Cancer Cells Cancer Res., September 1, 2007; 67(17): 8293 - 8300. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kotlo, D. E. Hughes, V. L.M. Herrera, N. Ruiz-Opazo, R. H. Costa, R. B. Robey, and R. S. Danziger Functional Polymorphism of the Anpep Gene Increases Promoter Activity in the Dahl Salt-Resistant Rat Hypertension, March 1, 2007; 49(3): 467 - 472. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pramila, W. Wu, S. Miles, W. S. Noble, and L. L. Breeden The Forkhead transcription factor Hcm1 regulates chromosome segregation genes and fills the S-phase gap in the transcriptional circuitry of the cell cycle. Genes & Dev., August 15, 2006; 20(16): 2266 - 2278. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Zhang, A. M. Ackermann, G. A. Gusarova, D. Lowe, X. Feng, U. G. Kopsombut, R. H. Costa, and M. Gannon The FoxM1 Transcription Factor Is Required to Maintain Pancreatic {beta}-Cell Mass Mol. Endocrinol., August 1, 2006; 20(8): 1853 - 1866. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Liu, B. Dai, S.-H. Kang, K. Ban, F.-J. Huang, F. F. Lang, K. D. Aldape, T.-x. Xie, C. E. Pelloski, K. Xie, et al. FoxM1B Is Overexpressed in Human Glioblastomas and Critically Regulates the Tumorigenicity of Glioma Cells. Cancer Res., April 1, 2006; 66(7): 3593 - 3602. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-M. Kim, T. Ackerson, S. Ramakrishna, M. Tretiakova, I-C. Wang, T. V. Kalin, M. L. Major, G. A. Gusarova, H. M. Yoder, R. H. Costa, et al. The Forkhead Box m1 Transcription Factor Stimulates the Proliferation of Tumor Cells during Development of Lung Cancer Cancer Res., February 15, 2006; 66(4): 2153 - 2161. [Abstract] [Full Text] [PDF] |
||||
![]() |
|